Davis Selected Advisers’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$596M Buy
2,233,929
+1,481,077
+197% +$410M 2.74% 14
2025
Q4
$207M Buy
752,852
+96,534
+15% +$27.1M 0.93% 28
2025
Q3
$189M Buy
656,318
+429
+0.1% +$127K 0.99% 28
2025
Q2
$217M Sell
655,889
-777,362
-54% -$251M 1.16% 26
2025
Q1
$472M Buy
1,433,251
+1,455
+0.1% +$438K 2.72% 13
2024
Q4
$395M Sell
1,431,796
-8,075
-0.6% -$2.57M 2.3% 16
2024
Q3
$499M Sell
1,439,871
-6,258
-0.4% -$2.15M 2.8% 13
2024
Q2
$478M Sell
1,446,129
-7,041
-0.5% -$2.43M 2.78% 13
2024
Q1
$528M Sell
1,453,170
-200,113
-12% -$65.9M 2.96% 14
2023
Q4
$495M Sell
1,653,283
-47,188
-3% -$13.8M 2.8% 12
2023
Q3
$486M Sell
1,700,471
-21,675
-1% -$6.18M 3.05% 13
2023
Q2
$483M Sell
1,722,146
-15,910
-0.9% -$4.14M 2.94% 14
2023
Q1
$444M Sell
1,738,056
-102,042
-6% -$29.7M 2.94% 15
2022
Q4
$610M Sell
1,840,098
-1,254,391
-41% -$397M 4.14% 8
2022
Q3
$859M Sell
3,094,489
-43,644
-1% -$12.3M 6.11% 4
2022
Q2
$827M Sell
3,138,133
-223,850
-7% -$57.7M 5.31% 4
2022
Q1
$806M Sell
3,361,983
-4,934
-0.1% -$1.16M 4.07% 8
2021
Q4
$773M Buy
3,366,917
+23,957
+0.7% +$5.09M 3.59% 11
2021
Q3
$669M Buy
3,342,960
+2,178,225
+187% +$474M 3.09% 15
2021
Q2
$276M Buy
1,164,735
+4,344
+0.4% +$1.08M 1.13% 24
2021
Q1
$281M Buy
1,160,391
+402,192
+53% +$89.6M 1.23% 24
2020
Q4
$158M Buy
758,199
+435,956
+135% +$85.5M 0.76% 26
2020
Q3
$54.6M Buy
322,243
+215
+0.1% +$37.8K 0.3% 35
2020
Q2
$60.4M Buy
322,028
+5,778
+2% +$1.1M 0.35% 33
2020
Q1
$56M Buy
316,250
+138,910
+78% +$26.9M 0.38% 34
2019
Q4
$36.3M Sell
177,340
-9,776
-5% -$1.79M 0.17% 51
2019
Q3
$28.4M Buy
187,116
+81,082
+76% +$13.2M 0.14% 54
2019
Q2
$16.7M Buy
106,034
+7,386
+7% +$1.16M 0.08% 75
2019
Q1
$15.9M Buy
98,648
+204
+0.2% +$37.3K 0.08% 83
2018
Q4
$18.7M Buy
+98,444
New +$20.5M 0.1% 65

Other funds holding CI

Davis Selected Advisers's CI Position: Q1 2026 in Review

Davis Selected Advisers increased its Cigna (CI) stake by 197% in Q1 2026, buying an estimated $410M and bringing the position to 2,233,929 shares worth $596M. The position accounts for 2.74% of the portfolio, ranked #14.

Davis Selected Advisers first reported a position in CI in Q4 2018 and has held it in 30 quarters since. The position peaked at $859M in Q3 2022. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Davis Selected Advisers held 2,233,929 shares of Cigna worth $596M as of Q1 2026.
  • Davis Selected Advisers bought 1,481,077 Cigna shares in Q1 2026, an estimated $410M.
  • Cigna made up 2.74% of Davis Selected Advisers's portfolio in Q1 2026, its #14 holding.
  • Davis Selected Advisers first reported a position in Cigna in Q4 2018 and has held it in 30 quarters since.
  • Davis Selected Advisers's Cigna position peaked at $859M in Q3 2022.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Davis Selected Advisers's 13F filing for Q1 2026, filed 7 May 2026.